Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Learn about common-over-the-counter (OTC) treatments for migraine attacks, including acetaminophen and NSAIDs such as aspirin ...

You're not imagining, says this headache expert—the skies and temperature play major roles. Follow his tips for reducing the ...

Treatment with 300 mg IV eptinezumab in adults with chronic migraine resulted in rapid and sustained reduction in the number of headache days that was largely sustained up to 84 weeks, according to a ...

Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating enough to interfere with daily activities. Despite a multitude of treatment ...

Patients with migraine discontinued treatment less often with atogepant and experienced a greater reduction in mean monthly ...

Atogepant 60 mg once daily leads to meaningful weight loss in patients with overweight or obesity receiving preventive ...

In adults with migraine and two-to-four previous preventive treatment failures, eptinezumab provided significant migraine preventive effects compared with placebo, with acceptable safety and ...

- Suffering from episodic migraines with and without aura occurring at least four times a month but less than 15 headache days a month at a severity of 5/10 pain level or greater. - Willing to not ...

Signs and symptoms of migraine can vary from person to person and attack to attack. Learn more about both common and rarer migraine symptoms. Menu. Newsletters Search. Health Conditions.